An anatomical classification of maxillary ameloblastoma as an aid to surgical treatment.
Maxillary ameloblastoma is a different entity from its mandibular counterpart. It is reported to behave more aggressively and have a poorer prognosis. Eleven maxillary ameloblastomas (three recurrent) are reported with a follow-up ranging from 1 month to 12 years with no recurrences. It is proposed that radical treatment of these tumours, with good reconstruction, can give satisfactory function and survival. To that end, the tumours have been classified as to their position in the maxilla and surgical resection related to this.
Jackson
I T
IT
Institute for Craniofacial and Reconstructive Surgery, Providence Hospital, Southfield, Michigan, USA.
Callan
P P
PP
Forté
R A
RA
D000328:Adult; D000564:Ameloblastoma / Q000145:classification / Q000473:pathology* / Q000601:surgery*; D017266:Dental Prosthesis; D005123:Eye / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008441:Maxillary Neoplasms / Q000145:classification / Q000473:pathology* / Q000601:surgery*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000473:pathology; D009915:Orbit / Q000473:pathology; D010027:Osteotomy / Q000379:methods; D017060:Patient Satisfaction; D011379:Prognosis; D016038:Skin Transplantation / Q000379:methods; D019291:Skull Base / Q000473:pathology; D013524:Surgical Flaps / Q000379:methods; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome